These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 63423)

  • 1. Oral fibrinolytic therapy. General review.
    Samama M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):363-71. PubMed ID: 63423
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic fibrinolytic agents.
    Davidson JF; Walker ID
    Prog Cardiovasc Dis; 1979; 21(5):375-96. PubMed ID: 154124
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological fibrinolysis.
    Chakrabarti R; Fearnley GR
    Acta Univ Carol Med Monogr; 1972; 52():15-7. PubMed ID: 4361262
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on pharmacological enhancement of blood fibrinolytic activity.
    Gormsen J; Laursen B
    Angiology; 1970 Sep; 21(8):546-51. PubMed ID: 4990278
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolytic substances in thrombosis therapy].
    Stamm H
    Ther Ggw; 1972 Mar; 111(3):335-42. PubMed ID: 4260163
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitamin E improves fibrinolytic activity in patients with coronary spastic angina.
    Miyamoto S; Kawano H; Takazoe K; Soejima H; Sakamoto T; Hokamaki J; Yoshimura M; Nakamura H; Yodoi J; Ogawa H
    Thromb Res; 2004; 113(6):345-51. PubMed ID: 15226088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of staphylokinase.
    Sweet B; McNicol GP; Douglas AS
    Clin Sci; 1965 Oct; 29(2):375-82. PubMed ID: 5840981
    [No Abstract]   [Full Text] [Related]  

  • 8. Hitting the target with antithrombotic therapy.
    Fritsma MG; Rodak BF
    MLO Med Lab Obs; 2007 May; 39(5):22, 24, 26 passim. PubMed ID: 18396734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombolytics. Principles and rules of use].
    Asseman P; Bauchart JJ; Auffray JL
    Rev Prat; 2001 Feb; 51(4):459-61. PubMed ID: 11355614
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biochemical basis for the control of anticoagulant and thrombolytic therapy].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):116-28. PubMed ID: 4098766
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
    Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
    Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologic principles of fibrinolytic therapy].
    Markwardt F
    Z Gesamte Inn Med; 1987 Sep; 42(17):473-8. PubMed ID: 3318182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.
    Hirsh J; Buchanan M; Glynn MF; Mustard JF
    J Lab Clin Med; 1968 Aug; 72(2):245-55. PubMed ID: 5671200
    [No Abstract]   [Full Text] [Related]  

  • 14. The fibrinolytic system in arteriosclerosis.
    O'Brien ET
    J Ir Med Assoc; 1969 Jun; 62(384):203-12. PubMed ID: 4892241
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of piyavit on hemostatic processes and fibrinolysis in patients with ischemic heart disease].
    Panchenko VM; Serebriakova TN; Podorol'skaia LV; Sorokoletov SM; Dzhanashiia PKh
    Eksp Klin Farmakol; 1995; 58(3):28-31. PubMed ID: 7663290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The antithrombotic and thrombolytic activity of tuftsin].
    Liapina LA; Pastorova VE; Kondashevskaia MV; Kudriashov BA; Kalikhevich VN; Kamenskiĭ AA; Ashmarin IP
    Biull Eksp Biol Med; 1993 Nov; 116(11):451-2. PubMed ID: 8312523
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitamins and minerals that affect hemostasis and antithrombotic therapies.
    Rebecca Couris R
    Thromb Res; 2005; 117(1-2):25-31; discussion 39-42. PubMed ID: 16257439
    [No Abstract]   [Full Text] [Related]  

  • 18. Apixaban, an oral direct factor Xa inhibitor, inhibits human clot-bound factor Xa activity in vitro.
    Jiang X; Crain EJ; Luettgen JM; Schumacher WA; Wong PC
    Thromb Haemost; 2009 Apr; 101(4):780-2. PubMed ID: 19350128
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombolytic activity of terrilytin and its effect on the coagulating system of the blood].
    Andreev SV; Kubatiev AA; Iurkov VA; Kol'tsova NL
    Biull Eksp Biol Med; 1976 Aug; 82(8):936-7. PubMed ID: 1026291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On thrombosis, thrombolysis and fibrinolysis. I. Thrombolytic therapy of deep venous thrombosis. II. Assay of individual fibrinolytic response.
    Robertson BR
    Acta Chir Scand Suppl; 1971; 421():1-51. PubMed ID: 5292287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.